| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |